Status:
COMPLETED
Randomized Clinical Trial to Increase Physical Activity After a a Hypertensive Pregnancy
Lead Sponsor:
University of Pennsylvania
Conditions:
Hypertension in Pregnancy
Preeclampsia
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
STEPUP is a 12-week randomized clinical trial among 126 postpartum women with pregnancies complicated by hypertensive disorders. Participants will be randomized to a control arm and receive a Fitbit o...
Detailed Description
Women with hypertensive disorders of pregnancy, such as preeclampsia and gestational hypertension, are at elevated risk of developing hypertension, diabetes, heart failure, and premature atherosclerot...
Eligibility Criteria
Inclusion
- Delivered a live baby at HUP or PAH within 4.0-12.6 weeks prior to study enrollment;
- Diagnosis of chronic hypertension, gestational hypertension, or preeclampsia during most recent pregnancy;
- Participating in Heart Safe Motherhood (HSM) program;
- Ability to read and provide informed consent to participate in the study;
- Has smartphone and email address
Exclusion
- Does not speak English
- Answers yes to any of the following questions:
- Are you currently participating in any other physical activity studies?
- Do you have any medical conditions or other reasons why you could not participate in a 12-week physical activity program?
- Participants will be excluded after completing the baseline period if their baseline step count is too high (greater than or equal to 10,000 steps per day).
Key Trial Info
Start Date :
October 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 5 2020
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT04119232
Start Date
October 10 2019
End Date
October 5 2020
Last Update
December 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104